Silicon Laboratories, Inc. $SLAB Shares Sold by Harbor Capital Advisors Inc.

Key Points

• Harbor Capital Advisors Inc. significantly reduced its stake in Silicon Laboratories by 77.7%, now holding 6,888 shares valued at approximately $1,015,000.
• Wall Street analysts have raised their price targets for Silicon Laboratories, with recommendations ranging from $130 to $180, indicating overall confidence in the stock's performance.
• Silicon Laboratories reported a 32.6% year-over-year revenue increase for the latest quarter, alongside earnings per share exceeding analysts' expectations, marking positive financial growth.

Harbor Capital Advisors Inc. cut its holdings in Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 77.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,888 shares of the semiconductor company's stock after selling 23,968 shares during the quarter. Harbor Capital Advisors Inc.'s holdings in Silicon Laboratories were worth $1,015,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the business. Quarry LP acquired a new position in Silicon Laboratories in the 1st quarter valued at about $25,000. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Silicon Laboratories in the 1st quarter valued at approximately $34,000. UMB Bank n.a. increased its holdings in shares of Silicon Laboratories by 111.3% in the first quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company's stock valued at $38,000 after purchasing an additional 177 shares during the period. Parallel Advisors LLC raised its stake in shares of Silicon Laboratories by 143.7% during the first quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company's stock worth $52,000 after purchasing an additional 273 shares during the last quarter. Finally, Larson Financial Group LLC purchased a new position in Silicon Laboratories in the 1st quarter valued at $55,000.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Stifel Nicolaus upped their price objective on shares of Silicon Laboratories from $144.00 to $160.00 and gave the stock a "buy" rating in a research report on Friday, July 18th. Benchmark reiterated a "buy" rating and set a $160.00 price target on shares of Silicon Laboratories in a research note on Tuesday, May 27th. Susquehanna raised their price objective on shares of Silicon Laboratories from $110.00 to $150.00 and gave the company a "neutral" rating in a research report on Tuesday, July 22nd. KeyCorp lifted their price objective on Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a report on Tuesday, July 8th. Finally, Morgan Stanley cut their target price on Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 6th. Five research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $151.13.

Silicon Laboratories Stock Down 0.1%

Shares of SLAB traded down $0.19 during trading hours on Monday, reaching $136.99. 174,493 shares of the company traded hands, compared to its average volume of 237,036. The stock has a market capitalization of $4.49 billion, a PE ratio of -42.54 and a beta of 1.52. Silicon Laboratories, Inc. has a fifty-two week low of $82.82 and a fifty-two week high of $160.00. The stock has a fifty day simple moving average of $135.25 and a 200 day simple moving average of $126.26.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.02. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The business had revenue of $192.85 million for the quarter, compared to the consensus estimate of $192.57 million. During the same quarter in the prior year, the firm posted ($0.56) earnings per share. The company's quarterly revenue was up 32.6% compared to the same quarter last year. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. Research analysts predict that Silicon Laboratories, Inc. will post -0.97 EPS for the current fiscal year.

Insider Buying and Selling at Silicon Laboratories

In other news, SVP Brandon Tolany sold 8,000 shares of the business's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $145.23, for a total transaction of $1,161,840.00. Following the completion of the sale, the senior vice president directly owned 62,328 shares of the company's stock, valued at $9,051,895.44. The trade was a 11.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In the last quarter, insiders have sold 12,070 shares of company stock valued at $1,703,472. 1.60% of the stock is owned by company insiders.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.